PT - JOURNAL ARTICLE AU - Szabo-Reed, Amanda N AU - Watts, Amber AU - Vidoni, Eric AU - Mahnken, Jonathan AU - Van Sciver, Angela AU - Finley, Katrina AU - Clutton, John AU - Holden, Rachel AU - Key, Mickeal AU - Burns, Jeff TI - Lifestyle Empowerment for Alzheimer's Prevention Prescribed by Physicians: Methods and Adaptations to COVID-19 AID - 10.1101/2024.07.29.24311181 DP - 2024 Jan 01 TA - medRxiv PG - 2024.07.29.24311181 4099 - http://medrxiv.org/content/early/2024/07/31/2024.07.29.24311181.short 4100 - http://medrxiv.org/content/early/2024/07/31/2024.07.29.24311181.full AB - The health care system is insufficiently capitalizing on the benefits of physical exercise in Americas aging population. Few practical tools exist to help clinicians incorporate physical activity into their clinical care, while significant barriers limit older adults from initiating and maintaining exercise programs. The Lifestyle Empowerment for Alzheimers Prevention (LEAP! Rx) Program will use two forms of participant enrollment: direct physician referrals through electronic health records (EHR) and self-referrals to test the efficacy of delivering a community-based exercise and healthy lifestyle program to older adults. After referral into the program, participants will be randomized to receive the LEAP! Rx Program or be placed on a standard of care waitlist. The LEAP! Rx program will consist of a personalized and structured exercise program combined with lifestyle education and mobile-health (m-Health) monitoring. This includes a 12-week Empowerment phase with intensive coaching and supervised exercise training, followed by a 40-week Lifestyle phase with intermittent supervised exercise and coaching. Lifestyle education includes monthly, evidence-based classes on optimal aging. This study will examine 1) the efficacy of the LEAP!Rx Program on increasing and sustaining cardiorespiratory fitness, 2) test the effect of the LEAP! Rx Program on secondary outcome measures of chronic disease risk factors, including insulin resistance, body composition, and lipids, and 3) assess the implementation and scalability of the LEAP!Rx Program for clinicians and patients and package best practices in implementation manuals. If successful, this studys findings could potentially revolutionize future healthcare practices, providing a new and practical approach to aging and chronic disease prevention.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis project was funded by the National Institute on Aging R01AG052954-01. Additional support was provided by P30 AG072973, the Clinical Translation Science Unit (UL1 TR002366), The Ann and Gary Dickinson Family Charitable Foundation, John and Marny Sherman, Brad and Libby Bergman, and GAP. T32 AG078114 supports Dr. Key.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This is a protocol manuscript. No human subjects data is reported.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Yes I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesThis is a protocol manuscript. No human subjects data is reported.